比卡鲁胺150 mg单药与单独药物去势治疗局部晚期前列腺癌的随机对照研究
비잡로알150 mg단약여단독약물거세치료국부만기전렬선암적수궤대조연구
Efficacy and safety of Bicalutamide 150 mg as the monotherapy in the treatment of locally advanced prostate cancer
  • 万方数据
    中华泌尿外科杂志 중화비뇨외과잡지
    CHINESE JOURNAL OF UROLOGY
    2009年 9期 614-618 ,共5页

    李宁忱%袁建峰%何学酉%洪宝发%姜昊文%丁强%那彦群

    리저침%원건봉%하학유%홍보발%강호문%정강%나언군

    前列腺肿瘤%癌%内分泌治疗%比卡鲁胺 前列腺腫瘤%癌%內分泌治療%比卡魯胺
    전렬선종류%암%내분비치료%비잡로알
    Prostatic neoplasms%Carcinoma%Hormonal therapy%Bicalutamide
    论 比卡鲁胺150 mg单药治疗局部晚期前列腺癌的安全性和耐受性良好,患者PSA下降程度和前列腺体积缩小程度与单独药物去势治疗相似,是一种新的治疗局部晚期、无远处转移前列腺癌安全、有效的方法.
    론 비잡로알150 mg단약치료국부만기전렬선암적안전성화내수성량호,환자PSA하강정도화전렬선체적축소정도여단독약물거세치료상사,시일충신적치료국부만기、무원처전이전렬선암안전、유효적방법.
    vides com-parable efficacy with medical castration in regard of decreasing PSA level and reducing prostate vol-ume. It is a safe and well tolerated treatment option as well.
    원문보기 원문다운로드 사이트로이동
저자의 최근 논문